← Back to headlines
Zevra Therapeutics to Present Long-Term Data on MIPLYFFA for Niemann-Pick Disease
Zevra Therapeutics will showcase new real-world evidence regarding MIPLYFFA treatment outcomes for Niemann-Pick Disease Type C patients at the upcoming 2026 SSIEM Annual Symposium.
25 Aug, 11:30 — 25 Aug, 11:30
